Summary
This in silico study integrated network pharmacology and molecular docking to elucidate the multi-target mechanism by which five bioactive compounds from green tea (Camellia sinensis) may act against coronary artery disease. Through analysis of 102 key CAD targets, the compounds were shown to interact with 48 common genes involved in inflammatory, oxidative stress, and metabolic pathways relevant to CAD pathogenesis. The findings suggest that green tea's cardioprotective effects may be mediated through multiple molecular targets and could inform development of herbal therapeutics, though the authors note that in vivo validation is necessary.
Regional applicability
The study is a computational analysis with no geographic restriction; findings on green tea phytochemistry and putative molecular targets are globally relevant. However, translation to United Kingdom clinical practice or dietary recommendations would require human clinical trials and evidence on bioavailability and efficacy in the target population.
Key measures
Gene-compound interactions, binding affinity scores, number of common target genes, interaction frequency with CAD-associated genes
Outcomes reported
The study identified 48 common genes through which five green tea compounds (theanine, caffeine, rutin, quercetin, epigallocatechin) interact with coronary artery disease targets, with five key genes (TERT, MMP2, MPO, CA2, MMP9) selected for further mechanistic analysis based on binding affinity and biological relevance.
Supporting research
Explicit green-tea constituents and their candidate cardiovascular mechanisms fit documented food-derived supporting mechanisms.
Limits: Computational network/docking hypothesis only; abstract prevention/treatment wording exceeds demonstrated evidence and must not be reproduced as established efficacy.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.